Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Conant Optical Co's EBIT per Share for the
six
months ended in Dec. 2025 was HK$0.77.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.59.
During the past 12 months, the average EBIT per Share Growth Rate of Shanghai Conant Optical Co was 12.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 19.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 16.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Shanghai Conant Optical Co's EBIT per Share or its related term are showing as below:
HKSE:02276'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 8.9 Med: 19 Max: 51.1
Current: 19
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Shanghai Conant Optical Co was 51.10% per year. The lowest was 8.90% per year. And the median was 19.00% per year.
HKSE:02276's 3-Year EBIT Growth Rate is ranked better than 64.08% of 682
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs HKSE:02276: 19.00
Shanghai Conant Optical Co (HKSE:02276) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Shanghai Conant Optical Co EBIT per Share Related Terms
Shanghai Conant Optical Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Conant Optical Co (HKSE:02276) has a EBIT per Share of HK$1.59 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shanghai Conant Optical Co and its competitors. According to the industry distribution chart, Shanghai Conant Optical Co ranks #245 out of 682 companies in the Medical Devices & Instruments industry, placing it in the top 35.9%.
Is Shanghai Conant Optical Co's EBIT per Share too high?
Shanghai Conant Optical Co's current EBIT per Share is HK$1.59. Based on the distribution chart, Shanghai Conant Optical Co ranks #245 out of 682 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai Conant Optical Co has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Conant Optical Co's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Conant Optical Co ranks #245 out of 682 companies for EBIT per Share. This puts Shanghai Conant Optical Co in the upper half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shanghai Conant Optical Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Conant Optical Co's current EBIT per Share is HK$1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Conant Optical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Conant Optical Co (HKSE:02276) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$15.71, compared to a current price of HK$44.62 — trading 184% above its estimated fair value. The current EBIT per Share is HK$1.59. Shanghai Conant Optical Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Shanghai Conant Optical Co (HKSE:02276), the current EBIT per Share is HK$1.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Conant Optical Co (HKSE:02276) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Conant Optical Co stock appears to be overvalued.
The current stock price of HK$44.62 is trading 184% above its estimated GF Value™ of HK$15.71.
GuruFocus considers Shanghai Conant Optical Co to be Significantly Overvalued.
Key valuation signals for HKSE:02276:
EBIT per Share: HK$1.59
GF Value™: HK$15.71 vs. price of HK$44.62 (184% above fair value)
No single metric tells the full story. See the HKSE:02276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 1-42, Lane 83, Hongxiang North Road, 4th Floor, Building 35, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone China, Shanghai, CHN
Shanghai Conant Optical Co Ltd is a resin spectacle lens manufacturer in China. The company offers a wide range of resin spectacle lenses to its customers including standardized lenses and customized lenses. The spectacle lenses are also tinted, coated, or cast with various films or coatings for added functionality, such as polarised, photochromic, blue-ray blocking, anti-scratch, anti-reflection, and anti-smudge. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the Americas, Europe, Oceania, Africa, and Asia (except for mainland China). It products include: CR-Freeform; CoMax; AC lens; Gaming Glassed, Antifog Lens; MyoEase; Polycarbonate lens; Photochromic coating lens; SingleVision Finished Lens; and Others.
74GF Score
Get the complete analysis for HKSE:02276
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02276 has been successfully added to your 
